Loading…
Back To Schedule
Monday, June 19 • 11:00am - 12:15pm
#125: Hybrid Study Designs: An Innovative Approach to Obtaining Valuable Information by Combining Existing Data with New Data Length

Sign up or log in to save this to your schedule, view media, leave feedback and see who's attending!

Tweet Share
Feedback form is now closed.
Component Type: Session
Level: Intermediate
CE: CME 1.25; IACET 1.25; RN 1.25

Speakers will share innovative approaches to obtaining valuable information by combining existing data with new data.

Learning Objectives

Define what constitutes a hybrid study design; Explain why hybrid designs are more cost efficient than traditional study designs; Describe at least one example of a hybrid study design.

Chair

Margaret S. Richards, PhD, MPH

Speaker

Leveraging Real-World Data to Plan and Execute Hybrid Studies for Peri- and Postapproval Drug and Device Research
Hady Khoury, MD

Why Choose a Hybrid Design? Insights from a Study with Duchenne Muscular Dystrophy Patients and Caregivers
William C. Maier, PhD, MPH

Feedback from a Hybrid Study in Oncology: Benefits of Combining Prospective Data and Existing Retrospective Data in One Place
Bertrand Le Bourgeois, MSc


Speakers
avatar for Bertrand Le Bourgeois

Bertrand Le Bourgeois

Sales and Marketing Director, Medsharing
Bertrand Le Bourgeois graduated as an engineer from Ecole Centrale in France, with a marketing specialisation from HEC Business School. He has spent his career in IT Consulting, with the last 15 years in the healthcare and pharma industries. Now Bertand acts as sales and marketing... Read More →
avatar for Hady Khoury

Hady Khoury

Vice President, Global Head, Research Services, Commercialization and Outcomes, ICON, plc.
Hady Khoury, VP and Global Head of Research Services, is a Medicine graduate with over 21 years of clinical research experience in the pharmaceutical industry. Hady has been instrumental in harmonizing and integrating operating models, using centralized site management, global hubs... Read More →
avatar for William Maier

William Maier

Chief Scientific Officer, Head, Patient-Centered Sciences, Mapi
Chief Scientific Officer (www.mapigroup.com) and Head of Patient-Centered Sciences. Dr Maier has over 20 years of experience in drug development and commercialization at global pharmaceutical companies. Currently, he works with pharmaceutical companies throughout the world to provide... Read More →
avatar for Margaret Richards

Margaret Richards

Vice President, Data Analytics and Epidemiology, RW Strategy and Analytics, Mapi
Dr. Margaret ‘Meg’ Richards has over 25 years' experience as an epidemiologist in the public health, biopharmaceutical, and contract research sectors. Prior to joining PPD as Executive Director of Epidemiology, Dr. Richards served as a Director of Global Patient Safety & Risk... Read More →

Monday June 19, 2017 11:00am - 12:15pm CDT
S404bc McCormick Place 2301 South Martin Luther King Jr. Drive, Gate 4 Chicago, IL 60616
  09: TranslSci-Preclin-Clin-ProdDev, Session
  • format json
  • Credit Type CME, IACET, RN
  • Tags Session